Dr. Reckeweg & Co. GmbH has a production site in Bensheim, Germany for homeopathic medicinal products in solid, semisolid, and liquid dosage forms. io acted as lead consultant for the new construction of production and logistics areas with clean rooms on a building area of approx. 11,000 m². Dr. Reckeweg invested €33 million in the site.
New clean-room production capacity was needed to relocate parts of the existing production as well as the manufacturing of new medicinal cannabis products. io developed a controlled substance security protocol for the production of cannabis products that are classified as narcotics (controlled substances). This involved implementing additional strong rooms, sophisticated intruder alarm systems and camera surveillance in the clean rooms. Production logistics functions are integrated into the new high-bay warehouse with 4,000 pallet spaces, and previously outsourced warehouse capacities were brought back in-house.
io drew on its many years of lead consulting in production and logistics to implement the project from concept design to go-live, including GMP qualification of all the involved parties. “The RCW3 project represents Dr. Reckeweg’s largest single investment to date. We commissioned io as lead consultant to make this highly complex investment project manageable.” said David Reckeweg-Lecompte, Managing Director at Dr. Reckeweg.
Implementation and comprehensive GMP qualification and monitoring were successfully completed and ratified by the regional council responsible for the approval of new pharmaceutical production facilities. The new facilities were then migrated from the former plant. Production is already under way at the new site.
